

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hetastarch
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : Aimee Eyvazzadeh
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Flourish HEC and BioGenesis to Improve Conception
Details : Hydroxyethylcellulose is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
May 25, 2022
Lead Product(s) : Hetastarch
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : Aimee Eyvazzadeh
Deal Size : Inapplicable
Deal Type : Inapplicable
